药物涂层球囊治疗冠状动脉分叉病变的研究进展OACSTPCD
Research progress of drug-coated balloon in the treatment of coronary bifurcation lesions
冠状动脉分叉病变占所有冠状动脉介入治疗病例的 15%～20%,其介入治疗策略的选择仍具争议.作为冠状动脉粥样硬化性心脏病介入治疗领域的新器械,药物涂层球囊逐渐被应用于分叉病变的介入治疗中,起到了简化操作程序、保护分支血管的作用.本文就药物涂层球囊在分叉病变介入治疗中的有效性及安全性的最新证据进行综述.
Coronary bifurcation lesions account for about 15%-20%of all cases of coronary intervention,and the choice of intervention strategy is still controversial.As a new device in the field of interventional treatment of coronary heart disease,drug-coated balloons have been gradually applied in the interventional treatment of bifurcation lesions,which plays a role in simplifying the operation procedure and protecting branch vessels.This article reviews the latest evidence on the efficacy and safety of drug-coated balloons in the interventional treatment of bifurcation lesions.
朱正茂;于雪
北京协和医学院研究生院,北京 100730||北京医院 心血管内科 国家老年医学中心 北京协和医学院 中国医学科学院,北京 100730
冠状动脉分叉病变经皮冠脉介入术药物涂层球囊
Coronary bifurcation lesionsPercutaneous coronary interventionDrug-coated balloon
《中国医学前沿杂志（电子版）》 2024 (002)
6-12 / 7
National High Level Hospital Clinical Research Funding(BJ-2022-124) 中央高水平医院临床科研业务费(BJ-2022-124)
评论